Search results

Page results

• Coping with loneliness - by Emma Breger, Support and information specialist

  Emma, our support and information specialist, gives tips to overcome loneliness.

• Facing the pandemic as a digital hospital

  Transforming UCLH into a truly digitally integrated hospital has paid dividends during our response to COVID-19. We are one of a handful of trusts to have done this.

• Being active: Information for people who are undergoing or have finished their cancer treatment

  This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing

• Latest UK Covid-19 Vaccine Study Launched at UCLH

  Volunteers are being asked to sign up to the latest Covid-19 vaccine study to begin across the UK including at UCLH.

• Managing the emotional impact of cancer: Information for people who are undergoing or have finished their cancer treatment

  This page aims to support and supplement the information provided in the video titled Managing the Emotional Impact of Cancer, available on uclh.nhs.uk/wellbeing.

• Adult allergy service

  This has been written by the Adult Allergy Clinic team at the Royal London Hospital for Integrated Medicine. It is intended for patients (or their family or carers) who may be referred to this clinic.

• COVID-19 tests: possible scam

  We have been alerted to a possible doorstep scam where members of the public are being offered COVID-19 tests.

• Daniell Regan: What do you, we, I see? (2022)

  An online exhibition by Dr Sarah Yardley and artist Daniel Regan, exploring the role of relationships and relationship-centred approaches to healthcare.

• Integrated Care Operations

  The aim of the Integrated Care Operations is to support the development of patient centred co-ordinated care for UCLH patients through collaborative working across the organisation and with the community, social and primary care.

• UCLH and UCL successfully complete world-first trial of a regenerative hearing drug

  UCLH and UCL researchers have successfully completed a world-first trial of a therapy designed to restore hearing loss.